Crossmark

Phase I clinical trial results of aceneuramic acid for GNE myopathy in Japan

Crossref DOI link: https://doi.org/10.1186/s41231-018-0025-0

Published Online: 2018-09-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Suzuki, Naoki http://orcid.org/0000-0001-8880-8554
Kato, Masaaki

Warita, Hitoshi

Izumi, Rumiko

Tateyama, Maki

Kuroda, Hiroshi

Asada, Ryuta

Suzuki, Akifumi

Yamaguchi, Takuhiro

Nishino, Ichizo

Aoki, Masashi
License Information

Text and Data Mining valid from 2018-09-06
More Information

Article History

Received: 10 May 2018

Accepted: 30 August 2018

First Online: 6 September 2018

Ethics approval and consent to participate

: The study protocol (including patient sample collection) was approved by the ethics committee of Tohoku University Hospital. Informed consent was obtained from all patients.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.